To view the full version of this video, please tell us more about yourself. »
Presenter(s):
Topic(s):
Myelodysplastic Syndromes (MDS)
Presentation Date:
Thursday, April 18, 2019
Dr. Amer Zeidan from Yale Cancer Center explains the different mutations found in MDS and answers the question -“Should patients with MDS ask about their cancer mutations?” He discusses how mutations impact prognosis and affect treatment decisions